2 research outputs found
Bioactive Constituents of <i>Indigofera spicata</i>
Four new flavanones, designated as
(+)-5ā³-deacetylpurpurin
(<b>1</b>), (+)-5-methoxypurpurin (<b>2</b>), (2<i>S</i>)-2,3-dihydrotephroglabrin (<b>3</b>), and (2<i>S</i>)-2,3-dihydrotephroapollin C (<b>4</b>), together
with two known flavanones (<b>5</b> and <b>6</b>), three
known rotenoids (<b>7</b>ā<b>9</b>), and one known
chalcone (<b>10</b>) were isolated from a chloroform-soluble
partition of a methanol extract from the combined flowers, fruits,
leaves, and twigs of <i>Indigofera spicata</i>, collected
in Vietnam. The compounds were obtained by bioactivity-guided isolation
using the HT-29 human colon cancer, 697 human acute lymphoblastic
leukemia, and Raji human Burkittās lymphoma cell lines. The
structures of <b>1</b>ā<b>4</b> were established
by extensive 1D- and 2D-NMR experiments, and the absolute configurations
were determined by the measurement of specific rotations and CD spectra.
The cytotoxic activities of the isolated compounds were tested against
the HT-29, 697, Raji, and CCD-112CoN human normal colon cells. Also,
the quinone reductase induction activities of the isolates were determined
using the Hepa 1c1c7 murine hepatoma cell line. In addition, <i>cis</i>-(6aĪ²,12aĪ²)-hydroxyrotenone (<b>7</b>) was evaluated in an in vivo hollow fiber bioassay using HT-29,
MCF-7 human breast cancer, and MDA-MB-435 human melanoma cells
Caeruleanone A, a Rotenoid with a New Arrangement of the DāRing from the Fruits of <i>Millettia caerulea</i>
Caeruleanone A (<b>1</b>), a novel rotenoid with an unprecedented
arrangement of the D-ring, was isolated with another two new analogues,
caeruleanones B (<b>2</b>) and C (<b>3</b>), together
with 11 known rotenoids from the fruits of <i>Millettia caerulea</i>. The structures of the new compounds were determined by spectroscopic
data analysis, with that of <b>1</b> being confirmed by single-crystal
X-ray diffraction. Compounds <b>2</b> and <b>3</b> displayed
potent mitochondrial transmembrane potential inhibitory and quinone
reductase induction activities